Research Topics
Species | Thomas KostenSummaryAffiliation: Yale University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Buprenorphine for office-based practice: consensus conference overviewThomas R Kosten
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
Am J Addict 13:S1-7. 2004..This opportunity has a three-year window, however, and a critical need will be to attract a sufficient number of physicians into prescribing buprenorphine/naloxone in order to allow our patients increased access to this treatment...
Management of drug and alcohol withdrawalThomas R Kosten
Departments of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA
N Engl J Med 348:1786-95. 2003
Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patientsThomas Kosten
Department of Psychiatry, Yale University School of Medicine, VA New England MIRECC, West Haven, CT 06516, USA
Addiction 98:665-71. 2003..The 'escalating CM' was eliminated during months 4-6 to assess any reduction in drug-free urines...
Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patientsThomas Kosten
Department of Psychiatry, Yale University School of Medicine, VA New England MIRECC, VA Caonnecticut Healthcare System, 950 Campbell Avenue, Bldg 35, West Haven, CT 06516, USA
Drug Alcohol Depend 70:315-25. 2003..DMI and CM had independent and additive effects in facilitating cocaine-free urines in buprenorphine maintained patients. The antidepressant appeared to enhance responsiveness to CM reinforcement...
Therapeutic vaccines for substance dependenceThomas R Kosten
Yale University School of Medicine, Department of Psychiatry, West Haven, Connecticut 06516, USA
Expert Rev Vaccines 1:363-71. 2002..Other immunotherapy may include treatment of drug overdose, prevention of brain or cardiac toxicity and protection of a fetus during pregnancy in a drug abuser...
Aspirin or amiloride for cerebral perfusion defects in cocaine dependenceThomas R Kosten
Department of Psychiatry, 151D, Yale University School of Medicine, VA Connecticut Healthcare System, 950 Campbell Avenue Bldg, Room 41, West Haven, CT 06516, USA
Drug Alcohol Depend 71:187-94. 2003..Platelet aggregation after ADP showed no significant change during the month, but reduced rCBF significantly improved after 1-month treatment with amiloride compared with placebo and cocaine abstinence alone...
The neurobiology of opioid dependence: implications for treatmentThomas R Kosten
Yale University School of Medicine, New Haven, Connecticut, USA
Sci Pract Perspect 1:13-20. 2002..Despite the effectiveness of medications, they must be used in conjunction with appropriate psychosocial treatments...
Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadoneThomas Kosten
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
Am J Addict 13:191-201. 2004..Cocaine-free urines showed no association with depression. This poor outcome with desipramine and buprenorphine suggests that this medication combination is not indicated in depressed opioid-dependent patients...
New medication strategies for comorbid substance use and bipolar affective disordersThomas R Kosten
Department of Psychiatry, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Biol Psychiatry 56:771-7. 2004..Pemoline might be the best option for minimizing the risk of SUD complicating comorbid ADHD with BPD...
Immunotherapy for the treatment of drug abuseThomas Kosten
Yale School of Medicine, Department of Psychiatry, West Haven, CT 06516, USA
Pharmacol Ther 108:76-85. 2005..Current immunotherapies already show efficacy, but improved antigen design and antibody engineering promise highly specific and rapidly developed treatments for both existing and future addictions...
Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of responseThomas Kosten
Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Am J Addict 14:8-17. 2005..The CU+ patients showed a treatment effect of DMI. This DMI effect was significant in patients maintained on BUP but not on Meth...
Ketoconazole increases cocaine and opioid use in methadone maintained patientsThomas R Kosten
Department of Psychiatry 151D, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Drug Alcohol Depend 66:173-80. 2002..Thus, in agreement with the negative results from acute dosing studies in primates and humans, chronic ketoconazole treatment does not appear to reduce cocaine or opioid use in humans maintained on methadone...
The Lexington narcotic farmThomas R Kosten
Department of Psychiatry, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Am J Psychiatry 159:22. 2002
Human therapeutic cocaine vaccine: safety and immunogenicityThomas R Kosten
Department of Psychiatry, School of Medicine, Yale University, 950 Campbell Avenue, West Haven, CT 06516, USA
Vaccine 20:1196-204. 2002..Thus, the therapeutic vaccine was well tolerated with dose related increases in antibody levels, and a high proportion of patients recruited into the study were retained...
Cue-induced brain activity changes and relapse in cocaine-dependent patientsThomas R Kosten
Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Neuropsychopharmacology 31:644-50. 2006..This physiological activation was a better predictor of relapse than subjective reports of craving, and may be a useful target for treatment development...
The potential of dopamine agonists in drug addictionThomas R Kosten
Yale University School of Medicine, VA Connecticut Healthcare System, Department of Psychiatry, West Haven, CT 06516, USA
Expert Opin Investig Drugs 11:491-9. 2002..Animal studies also suggest that tailoring treatment to subgroups of patients based on genotype may improve responses...
Preliminary study of buprenorphine and bupropion for opioid-dependent smokersMarc E Mooney
Department of Psychiatry, Transdisciplinary Tobacco Use Research Center, University of Minnesota, Minneapolis, Minnesota 55414, USA
Am J Addict 17:287-92. 2008..These preliminary findings do not support the efficacy of BUPRO, in combination with BUPRE, for the concurrent treatment of opioid and tobacco addiction...
Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokersMehmet Sofuoglu
Department of Psychiatry, VA Connecticut Healthcare System, School of Medicine, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
Psychopharmacology (Berl) 184:645-51. 2006..While a recent clinical study has demonstrated the potential utility of topiramate for smoking cessation in alcohol-dependent smokers, the effects of topiramate on tobacco addiction have not been systematically examined in humans...
Disulfiram enhances subjective effects of dextroamphetamine in humansMehmet Sofuoglu
Yale University, Department of Psychiatry, VA Connecticut Healthcare System, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, United States
Pharmacol Biochem Behav 90:394-8. 2008..How these enhanced subjective amphetamine responses affect cocaine use behavior remains to be determined in future clinical trials...
Atomoxetine attenuates dextroamphetamine effects in humansMehmet Sofuoglu
Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, West Haven, CT 06516, USA
Am J Drug Alcohol Abuse 35:412-6. 2009..Although preclinical studies support the contribution of the noradrenergic system activation in mediating the acute effects of amphetamines, these findings have not been followed up in clinical studies...
Adrenergic blocker carvedilol attenuates the cardiovascular and aversive effects of nicotine in abstinent smokersMehmet Sofuoglu
Department of Psychiatry and Veterans Administration Connecticut Healthcare System, School of Medicine, Yale University, West Haven, CT 06515, USA
Behav Pharmacol 17:731-5. 2006..Attenuation of the rating of 'bad effects' by carvedilol suggests that noradrenergic activation may also mediate the aversive effects of nicotine...
Minocycline attenuates subjective rewarding effects of dextroamphetamine in humansMehmet Sofuoglu
Department of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, 950 Campbell Avenue, West Haven, CT 06516, USA
Psychopharmacology (Berl) 213:61-8. 2011..The goal of this study was to determine minocycline's effects on the acute physiological, behavioral, and subjective responses to dextroamphetamine (DAMP) in healthy volunteers...
Cocaine withdrawal symptoms predict medication response in cocaine usersMehmet Sofuoglu
Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Am J Drug Alcohol Abuse 32:617-27. 2006..This hypothesis needs to be tested in prospective clinical trials...
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practiceStacey C Sigmon
Department of Psychiatry, University of Vermont College of Medicine, Burlington, 05401, USA
Am J Drug Alcohol Abuse 38:187-99. 2012..e., methadone, buprenorphine) often produces favorable outcomes, detoxification followed by treatment with the μ-opioid receptor antagonist naltrexone may offer a potentially useful alternative to agonist maintenance for some patients...
Riluzole and D-amphetamine interactions in humansMehmet Sofuoglu
Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, United States
Prog Neuropsychopharmacol Biol Psychiatry 32:16-22. 2008..The mechanism accounting for these findings is unclear, but may involve processes other than decreased glutamate release by riluzole. The effects of glutamate medications on psychostimulant responses need to be further examined...
Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokersMehmet Sofuoglu
Department of Psychiatry, VA Connecticut Healthcare System, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
Psychopharmacology (Berl) 181:504-10. 2005..These preclinical studies have not been followed up in systematic human studies...
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to actionDennis S Charney
Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104-6178, USA
Biol Psychiatry 56:703-13. 2004
Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging studyKelly P Cosgrove
Yale University School of Medicine and the VACHS, New Haven, CT 06516, United States
Psychiatry Res 184:192-5. 2010..Heroin users had statistically similar striatal DA and brainstem and diencephalon 5-HT transporter availability compared with controls. No associations between transporter availability and heroin use characteristics were found...
Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic researchRungnapa Hirunsatit
Yale University School of Medicine, Department of Psychiatry, New Haven, CT, USA
BMC Genet 8:71. 2007....
Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary dataNashaat N Boutros
VA-Connecticut Healthcare System West Haven Campus, Yale University School of Medicine, 950 Campbell Avenue (116A, West Haven, CT 06516, USA
Biol Psychiatry 51:683-6. 2002..Further exploration of these factors seems warranted...
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained populationJames Poling
Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, West Haven 06516, USA
Arch Gen Psychiatry 63:219-28. 2006..No effective pharmacotherapies exist for cocaine dependence, although contingency management (CM) has demonstrated efficacy...
Tiagabine affects the subjective responses to cocaine in humansMehmet Sofuoglu
Yale University, School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, West Haven, CT, USA
Pharmacol Biochem Behav 82:569-73. 2005..GABA medications, including tiagabine, are currently being evaluated in controlled clinical trials for the treatment of cocaine dependence...
Treatment outcome predictors for cocaine dependenceJames Poling
Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System West Haven, CT 06516, USA
Am J Drug Alcohol Abuse 33:191-206. 2007..Initial promising findings with genetic polymorphism, brain activation, and stress response have also been found and need to be replicated in future studies...
Pharmacogenetic treatments for drug addiction: alcohol and opiatesColin N Haile
Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas 77030, USA
Am J Drug Alcohol Abuse 34:355-81. 2008..This review aims to cover these developments in the pharmacotherapy of alcohol and opiates, two addictive drugs for which we have the majority of our FDA approved pharmacotherapies...
Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot studyMehmet Sofuoglu
Department of Psychiatry, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, Connecticut, USA
Exp Clin Psychopharmacol 15:453-60. 2007..60 vs. 0.73; U=4837, p<.04). These preliminary findings do not support the efficacy of progesterone in male cocaine users. The efficacy of progesterone in female cocaine users remains to be determined in future studies...
Vaccine pharmacotherapy for the treatment of cocaine dependenceBridget A Martell
Section of General Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Biol Psychiatry 58:158-64. 2005..Cocaine abuse has no established pharmacotherapy, but active immunotherapy with a cocaine vaccine shows promise as a therapeutic intervention...
Cerebral perfusion defects in combined cocaine and alcohol dependenceP C Gottschalk
Departments of Veterans and Psychiatry 116A, Yale University School of Medicine, VA Connecticut Healthcare System, Psychiatry 151D, 950 Campbell Avenue, Building 35, Room 41, West Haven, CT 06516, USA
Drug Alcohol Depend 68:95-104. 2002....
Pharmacotherapeutic environments for substance use disordersTracie J Gardner
Am J Drug Alcohol Abuse 33:627-9. 2007
Nicotine dependence, symptoms and oxidative stress in male patients with schizophreniaXiang Yang Zhang
Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 2002 Holcombe Boulevard, Houston, TX 77030, USA
Neuropsychopharmacology 32:2020-4. 2007....
Association of spirituality and sobriety during a behavioral spirituality intervention for Twelve Step (TS) recoveryAnthony E Brown
Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas 77098, USA
Am J Drug Alcohol Abuse 33:611-7. 2007..These findings encourage a controlled trial to determine if this work has efficacy for practitioners in substance abuse treatment...
Treatment of patients with substance use disorders, second edition. American Psychiatric AssociationHerbert D Kleber
Am J Psychiatry 164:5-123. 2007
Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findingsRajita Sinha
Department of Psychiatry, Yale University School of Medicine, 34 Park Street, Room S110, New Haven, CT 06519, USA
Psychopharmacology (Berl) 190:569-74. 2007..A preliminary study examined whether lofexidine decreases stress-induced and cue-induced opioid craving and improves opioid abstinence in naltrexone-treated opioid-dependent individuals...
Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patientsJames Poling
Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT 06516, USA
Am J Addict 16:187-94. 2007..The results indicate that neither citalopram nor citalopram augmented with bupropion were more effective than placebo in the treatment of opioid abuse...
Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patientsGerardo Gonzalez
Department of Psychiatry, Yale University, New Haven, CT 06511, USA
Drug Alcohol Depend 87:1-9. 2007..GABAergic medications appear to reduce the reinforcing effects of cocaine by attenuating cocaine-induced dopamine release. This study evaluated gabapentin and tiagabine compared to placebo in reducing cocaine taking behavior...
Emerging pharmacological strategies in the fight against cocaine addictionMehmet Sofuoglu
Department of Psychiatry, VA Connecticut Healthcare System, Yale University, School of Medicine, West Haven, CT 06516, USA
Expert Opin Emerg Drugs 11:91-8. 2006..Last, a cocaine vaccine that slows entry of cocaine into the brain holds promise. These promising findings need to be further tested in controlled clinical trials...
Antisocial personality and stress-induced brain activation in cocaine-dependent patientsChiang Shan R Li
Department of Psychiatry, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, Connecticut 06519, USA
Neuroreport 17:243-7. 2006..These results highlight important sex differences in the association between antisocial personality and distress processing in cocaine-dependent individuals...
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging studyRajita Sinha
Department of Psychiatry, Yale University School of Medicine, 34 Park Street, Room S110, New Haven, CT 06519, USA
Psychopharmacology (Berl) 183:171-80. 2005..Identifying neural activity associated with stress and stress-induced cocaine craving is important in understanding the neurobiology of cocaine craving and relapse...
The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjectsDanielle Abi-Saab
Yale University School of Medicine, VA Connecticut Healthcare System, Department of Psychiatry, West Haven, Connecticut 06516, USA
Am J Addict 14:166-78. 2005..The vasodilatation produced by alcohol may attenuate some of the vasoconstriction and neurotoxic effects of cocaine, accounting for the fewer deficits in this group...
Therapeutic vaccines for substance dependenceMargaret Haney
College of Physicians and Surgeons of Columbia University and the New York State Psychiatric Institute, Department of Psychiatry, New York, NY 10032, USA
Expert Rev Vaccines 3:11-8. 2004..Overall, immunotherapy offers a range of potential treatment options: drug treatment, as well as the treatment of overdose, prevention of brain or cardiac toxicity and fetal protection in pregnant drug abusers...
Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependenceMehmet Sofuoglu
Department of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, West Haven, Connecticut 06516, USA
Am J Drug Alcohol Abuse 29:713-27. 2003..These results suggest that baseline cocaine urine results should be considered as stratifying variables in clinical trials for cocaine dependence...
Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot studyGerardo Gonzalez
Department of Psychiatry, Yale University School of Medicine, West Haven, CT, USA
Addiction 98:1625-32. 2003..We sought to evaluate the safety and efficacy of the GABAergic agent tiagabine in reducing cocaine use among methadone-treated patients...
Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in ratsColin N Haile
Department of Neurosurgery, Thomas Jefferson Medical College, Philadelphia, Pennsylvania, USA
Biol Psychiatry 54:915-21. 2003..CONCLUSIONS: Because DS shows treatment efficacy for cocaine addiction, results from this study suggest potential treatment agents should enhance, not attenuate, locomotor sensitization in rats...
Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency managementGerardo Gonzalez
Department of Psychiatry, Yale University School of Medicine, and VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Am J Drug Alcohol Abuse 29:497-514. 2003..The ND cocaine-abusing, opiate-dependent patients may be more responsive to the anticraving effects of DMI...
Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humansMehmet Sofuoglu
Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA
Pharmacol Biochem Behav 75:801-8. 2003..These results suggest that isradipine alone or in combination with naltrexone attenuates some of the physiological effects of cocaine...
D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedureAlison Oliveto
Department of Psychiatry, Yale School of Medicine and Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Exp Clin Psychopharmacol 11:237-46. 2003..Naloxone attenuated D-cycloserine-induced increases in systolic blood pressure. These results suggest that D-cycloserine at doses up to 500 mg/70 kg may have some limited usefulness in relieving symptoms of opioid withdrawal...
Coordination of medical care and opioid dependence treatment in primary care: a case reportDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
Subst Abus 24:43-6. 2003
Isradipine enhancement of cerebral blood flow in abstinent cocaine abusers with and without chronic perfusion deficitsP C H Gottschalk
Department of Psychiatry, Yale University School of Medicine and the VA Connecticut Healthcare System, West Haven, Conn 06516, USA
Am J Addict 11:200-8. 2002..These deficits may represent segmental cerebral vasospasm that was reversed by this vasodilating agent in cocaine abusers with areas of hypo-perfusion (deficits) as baseline...
A placebo controlled trial of bupropion for smoking cessation in schizophreniaTony P George
Program for Research in Smokers with Mental Illness and Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
Biol Psychiatry 52:53-61. 2002....
Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusersAlan Feingold
Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven 06516, USA
Am J Addict 11:111-23. 2002....
Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patientsSusan M Stine
Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 2761 E. Jefferson Avenue, Detroit, MI 48207, USA
Biol Psychiatry 51:642-51. 2002..Medications that increase synaptic noradrenaline should be used with care in opioid-dependent patients...
Gender-specific vulnerability for rCBF abnormalities among cocaine abusersKaren A Tucker
Department of Psychiatry, VA Connecticut Healthcare System, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT 06516, USA
Neuroreport 15:797-801. 2004..The possibility of different neural mechanisms underlying relapse in men and women, and the implications for utilizing specialized treatments are discussed...
Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusersJeffrey N Browndyke
Department of Psychiatry and Human Behavior Brown Medical School, Providence, Rhode Island, USA
J Neuroimaging 14:162-9. 2004..While perfusion abnormalities have been shown to relate to cognitive deficits in this substance abuse population, the relationship between cognitive performance and the magnitude of perfusion abnormality has yet to be fully determined...
Combating opiate dependence: a comparison among the available pharmacological optionsGerardo Gonzalez
Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
Expert Opin Pharmacother 5:713-25. 2004....
Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patientsAlison Oliveto
Department of Psychiatry, Yale School of Medicine and the VA CT Healthcare System, West Haven, CT, USA
Drug Alcohol Depend 79:157-65. 2005..These results suggest that an efficacious maintenance dose is necessary for contingencies to be effective in facilitating both opioid and cocaine abstinence...
Sex differences in brain activation during stress imagery in abstinent cocaine users: a functional magnetic resonance imaging studyChiang Shan Ray Li
Department of Psychiatry, Yale University, New Haven, Connecticut 06519, USA
Biol Psychiatry 57:487-94. 2005....
Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findingsNashaat N Boutros
Department of Psychiatry, c o VA Connecticut Healthcare System, Yale University School of Medicine, 950 Campbell Avenue, 116A West Haven, CT 06516, USA
J Psychiatr Res 39:295-302. 2005..These data support our initial finding of decreased cortical excitability in abstinent cocaine-dependent subjects. We interpret this finding as a compensatory mechanism against the stimulating and epileptogenic effects of cocaine...
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependenceRichard S Schottenfeld
Department of Psychiatry, Yale University School of Medicine, 34 Park St, Rm S204, New Haven, CT 06519, USA
Am J Psychiatry 162:340-9. 2005..This study compares effects of buprenorphine and methadone and evaluates the efficacy of combining contingency management with maintenance treatment for patients with co-occurring cocaine and opioid dependence...
Novel approaches to the treatment of cocaine addictionMehmet Sofuoglu
School of Medicine, Department of Psychiatry and VA Connecticut Healthcare System, Yale University, 950 Campbell Ave, Bldg 36 116A4, West Haven, CT 06516, USA
CNS Drugs 19:13-25. 2005..The efficacy of this vaccine for relapse prevention is under investigation. Many initial promising findings need to be replicated in larger, controlled clinical trials...
Pharmacologic management of relapse prevention in addictive disordersMehmet Sofuoglu
Yale University, School of Medicine, Department of Psychiatry, West Haven, CT, USA
Psychiatr Clin North Am 27:627-48. 2004..Further research is needed to develop new pharmacotherapies for substance use disorders and establish clinical guidelines on how to use these medications most effectively...
Perfusion abnormalities and decision making in cocaine dependenceKaren A Tucker
Department of Psychiatry, Yale University School of Medicine, New Haven, USA
Biol Psychiatry 56:527-30. 2004..This study examined whether cocaine-dependent patients have perfusion abnormalities associated with poor decision-making ability as measured by the Iowa Gambling Task (IGT)...
Consensus statement on office-based treatment of opioid dependence using buprenorphineDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
J Subst Abuse Treat 27:153-9. 2004....
Effects of progesterone treatment on cocaine responses in male and female cocaine usersMehmet Sofuoglu
Department of Psychiatry and VA Connecticut Healthcare System, School of Medicine, Yale University, West Haven, CT 06516, USA
Pharmacol Biochem Behav 78:699-705. 2004..The effects of progesterone treatment on cocaine dependence need to be further studied in controlled trials...
Choosing a behavioral therapy platform for pharmacotherapy of substance usersKathleen M Carroll
Department of Psychiatry, Yale University School of Medicine, VA CT Healthcare Center, 950 Campbell Avenue, West Haven, CT 06516, USA
Drug Alcohol Depend 75:123-34. 2004..Available manualized behavioral treatments are reviewed, noting their strengths and limitations as behavioral therapy platforms for pharmacotherapy trials and as potential concomitant therapies in clinical practice...
Challenges in increasing access to buprenorphine treatment for opiate addictionJoyce C West
Psychiatric Research Network, American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209, USA
Am J Addict 13:S8-16. 2004..Increasing the understanding of specific financing and services delivery barriers that clinicians face is needed to inform the development of effective integrated services models and policies to facilitate OBOT implementation...
Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedureAlison Oliveto
CT and VA Connecticut Healthcare System, Yale University, New Haven, 950 Campbell Avenue, Psychiatry 116A 4, Building 36, West Haven, CT 06516, USA
Eur J Pharmacol 491:157-68. 2004..These results suggest that isradipine attenuates and dextromethorphan enhances some of the behavioral effects of naloxone in opioid-dependent humans...
Effects of smoking abstinence on visuospatial working memory function in schizophreniaTony P George
Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA
Neuropsychopharmacology 26:75-85. 2002..These results suggest that smoking abstinence differentially alters VSWM in schizophrenic vs. control smokers, and that cigarette smoking has beneficial effects on VSWM in schizophrenic, but not control, smokers...
Research Grants
- Pharmacotherapy for opioid and cocaine dependenceBruce Rounsaville; Fiscal Year: 2005..4. To examine depression as a predictor of response. 5. To examine three month follow-up status after completing the treatment trial for continuation in treatment, abstinence from illicit drugs, and depressive symptoms. ..
